Cardiovascular Outcomes of Type 2 Diabetic Patients Treated With DPP-4 Inhibitors Versus Sulphonylureas As Add-on to Metformin in Clinical Practice (2021)

First Author: Bazo-Alvarez J
Attributed to:  Design of Trials, Meta-analyses and observational studies funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.21203/rs.3.rs-575651/v1

Publication URI: http://dx.doi.org/10.21203/rs.3.rs-575651/v1

Type: Preprint